NYSE$DLB
Dolby Laboratories Inc. · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Dolby's financial performance declined due to COVID-19 impacts, with revenue and net income decreasing compared to the previous year.
Dolby Laboratories reported Q4 2020 financial results with a decrease in revenue to $271.2 million compared to $298.8 million in Q4 2019. GAAP net income decreased to $26.8 million, or $0.26 per diluted share, compared to $43.9 million, or $0.43 per diluted share in Q4 2019. The results reflect the ongoing impact of the COVID-19 pandemic on various markets.
- Q4 revenue decreased to $271.2 million from $298.8 million year-over-year.
- GAAP net income for Q4 was $26.8 million, or $0.26 per diluted share, down from $43.9 million, or $0.43 per diluted share year-over-year.
- Non-GAAP net income for Q4 was $45.8 million, or $0.45 per diluted share, compared to $67.6 million, or $0.66 per diluted share year-over-year.
- Cash flows from operations for Q4 was $112.7 million, compared to $130.5 million year-over-year.
Headline financials
Revenue & EPS history
Dolby · Revenue · Quarterly
$271M
Revenue by segment
Dolby · $291M total across 2 segments · Q4 2023
- Licensing$265M—91.3%
- Products and services$25.4M—8.7%
Forward guidance
Dolby anticipates ongoing impacts from COVID-19 on unit volume shipments and the global cinema market, leading to continued economic uncertainty and difficulty in predicting future results. The company has provided estimates for the first and second quarters of fiscal year 2021, but actual results could differ materially due to the challenging economic environment and the uncertain effects of COVID-19.
Headwinds
- Unit volume shipments continue to be impacted and difficult to predict due to economic uncertainty caused by COVID-19.
- The global cinema market has been adversely impacted by COVID-19 due to site closures or reduced utilization.
- Cinema sites could continue to be negatively affected through the first half of fiscal 2021 or longer.
- Estimates for future periods reflect certain assumptions about the potential impact of COVID-19, which may not materialize.
- Actual results could differ materially from provided estimates due to the challenging economic environment and uncertain effects of COVID-19.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
-0.9%
Avg return
Earnings day
-1.2%
Avg return
5 days after
-0.5%
Avg return
30 days after
43%
29 / 68 earnings
Positive
+14.9%
Q4 2024
Best reaction
-24.2%
Q3 2011
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -10.5% | -9.6% | -13.0% | |
| Q1 2026 | +1.8% | +2.3% | +5.6% | |
| Q4 2025 | -0.0% | +2.8% | +2.0% | |
| Q2 2025 | -1.9% | -3.6% | -2.5% | |
| Q1 2025 | +8.3% | +4.6% | +1.2% | |
| Q4 2024 | +14.9% | +12.9% | +8.6% | |
| Q3 2024 | -7.6% | -9.3% | -6.9% | |
| Q2 2024 | +5.8% | +6.9% | +4.4% | |
| Q1 2024 | -3.5% | -4.5% | -1.0% | |
| Q4 2023 | -8.0% | -4.1% | -1.3% | |
| Q3 2023 | -9.8% | -11.7% | -3.2% | |
| Q2 2023 | +2.3% | +1.6% | +0.8% | |
| Q1 2023 | +7.4% | +5.5% | +3.8% | |
| Q4 2022 | -1.5% | -0.8% | +1.0% | |
| Q3 2022 | +0.9% | +3.0% | -5.7% | |
| Q2 2022 | -9.0% | -8.0% | -0.9% | |
| Q1 2022 | -13.8% | -13.0% | -17.7% | |
| Q4 2021 | -1.0% | +1.2% | +4.0% | |
| Q3 2021 | +1.6% | +4.4% | +4.7% | |
| Q2 2021 | -6.2% | -6.5% | -7.7% | |
| Q1 2021 | +1.7% | +5.3% | +12.7% | |
| Q4 2020 | +3.8% | +6.3% | +8.4% | |
| Q3 2020 | +1.9% | +0.8% | +2.0% | |
| Q2 2020 | -5.1% | -0.1% | +8.7% | |
| Q1 2020 | -0.5% | +1.0% | -5.3% | |
| Q4 2019 | +5.6% | +6.3% | +3.2% | |
| Q3 2019 | -13.6% | -14.1% | -9.6% | |
| Q2 2019 | +0.8% | +0.9% | -4.2% | |
| Q1 2019 | +3.1% | +3.5% | +3.7% | |
| Q4 2018 | -3.0% | -3.6% | +0.4% | |
| Q3 2018 | +5.3% | -0.7% | +11.7% | |
| Q2 2018 | -7.6% | -10.1% | -8.5% | |
| Q1 2018 | +8.5% | +2.1% | -3.7% | |
| Q4 2017 | -5.3% | -5.1% | +4.1% | |
| Q3 2017 | +2.4% | -1.5% | -8.0% | |
| Q2 2017 | -0.1% | -3.6% | -3.9% | |
| Q1 2017 | -1.6% | -2.9% | -0.7% | |
| Q4 2016 | -3.4% | -4.9% | -5.9% | |
| Q3 2016 | -1.0% | -1.3% | -1.1% | |
| Q2 2016 | +12.3% | — | — | |
| Q1 2016 | +10.7% | — | — | |
| Q4 2015 | +2.8% | — | — | |
| Q3 2015 | -5.7% | — | — | |
| Q2 2015 | +9.5% | — | — | |
| Q1 2015 | -7.9% | — | — | |
| Q4 2014 | +0.7% | — | — | |
| Q3 2014 | +2.0% | — | — | |
| Q2 2014 | -8.7% | — | — | |
| Q1 2014 | +1.5% | — | — | |
| Q4 2013 | +2.1% | — | — | |
| Q3 2013 | -1.3% | — | — | |
| Q2 2013 | +4.6% | — | — | |
| Q1 2013 | +1.3% | — | — | |
| Q4 2012 | -3.5% | — | — | |
| Q3 2012 | -14.9% | — | — | |
| Q2 2012 | +14.3% | — | — | |
| Q1 2012 | +6.4% | — | — | |
| Q2 2011 | -2.2% | — | — | |
| Q4 2011 | -2.2% | — | — | |
| Q3 2011 | -24.2% | — | — | |
| Q1 2011 | -2.2% | — | — | |
| Q1 2010 | -2.2% | — | — | |
| Q2 2010 | -1.0% | — | — | |
| Q4 2008 | -1.0% | — | — | |
| Q4 2010 | -1.0% | — | — | |
| Q4 2009 | -4.5% | — | — | |
| Q3 2010 | -4.5% | — | — | |
| Q3 2009 | -4.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro